Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1025-023 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Parke-Davis | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study of efficacy & safety of oral YM087 in subjects with euvolemic or hypervolemic hyponatremia
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| YM087 oral | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| Change in serum sodium from Baseline Safety of each dosing regimen | Beginning through end of treatment |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Art Wheeler, MD | Cumberland Pharmaceuticals, Inc. | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Brussels | Belgium | |||||
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Liège |
| Belgium |
| Tournai | Belgium |
| Jyväskylä | Finland |
| Turku | Finland |
| Garches | France |
| Limoges | France |
| Paris | France |
| Bad Nauheim | Germany |
| Berlin | Germany |
| Dresdan | Germany |
| Göttingen | Germany |
| München | Germany |
| Ferrara | Italy |
| Pavia | Italy |
| Pisa | Italy |
| Verona | Italy |
| Delft | Netherlands |
| Groningen | Netherlands |
| Leiden | Netherlands |
| Nijmegen | Netherlands |
| Radomsko | Poland |
| Warsaw | Poland |
| Wroclaw | Poland |
| Barcelona | Spain |
| Córdoba | Spain |
| Madrid | Spain |
| Cardiff | United Kingdom |
| Manchester | United Kingdom |
| ID | Term |
|---|---|
| D007010 | Hyponatremia |
| ID | Term |
|---|---|
| D014883 | Water-Electrolyte Imbalance |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C106389 | conivaptan |
Not provided
Not provided
Not provided